UCLM802 / UTC Therap - LARVOL DELTA

Anti-Mesothelin CAR-T Cell Injection in Patients With Mesothelin-positive Advanced Malignant Solid Tumors (clinicaltrials.gov) - P=N/A | N=24 | Recruiting | Sponsor: Zhejiang University

New trial • Solid Tumor

UCLM802 (Anti-Mesothelin CAR-T) Cell Injection in Patients With Mesothelin-positive Advanced Malignant Solid Tumors (clinicaltrials.gov) - P1 | N=87 | Recruiting | Sponsor: Zhejiang University

New P1 trial • Biliary Tract Cancer • Breast Cancer • Endometrial Cancer • Esophageal Cancer • Gastric Cancer • Gastrointestinal Cancer • Lung Cancer • Oncology • Ovarian Cancer • Solid Tumor • IL10 • IL6 • MSLN

MSLN-targeted CAR-T Cells in Solid Tumors. (clinicaltrials.gov) - P1 | N=87 | Not yet recruiting | Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences

CAR T-Cell Therapy • Metastases • New P1 trial • Biliary Tract Cancer • Breast Cancer • Endometrial Cancer • Esophageal Cancer • Gastric Cancer • Gastrointestinal Cancer • Lung Cancer • Oncology • Ovarian Cancer • Solid Tumor • IL10 • IL6 • MSLN

UCLM802 (Anti-Mesothelin CAR-T) Cell Injection in Patients With Mesothelin-positive Advanced Malignant Solid Tumors (clinicaltrials.gov) - P1 | N=87 | Not yet recruiting | Sponsor: Peking University

CAR T-Cell Therapy • Metastases • New P1 trial • Biliary Tract Cancer • Breast Cancer • Endometrial Cancer • Esophageal Cancer • Gastric Cancer • Gastrointestinal Cancer • Lung Cancer • Oncology • Ovarian Cancer • Solid Tumor • IL10 • IL6 • MSLN

Exploratory Study of Novel MSLN CAR-T Cell Therapy in Patients With MSLN-positive Advanced Refractory Solid Tumors (clinicaltrials.gov) - P1 | N=0 | Withdrawn | Sponsor: Shanghai Pudong Hospital | N=20 ➔ 0 | Recruiting ➔ Withdrawn

CAR T-Cell Therapy • Enrollment change • Metastases • Trial withdrawal • Oncology • Solid Tumor • MSLN

Exploratory Study of Novel MSLN CAR-T Cell Therapy in Patients With MSLN-positive Advanced Refractory Solid Tumors (clinicaltrials.gov) - P1 | N=20 | Recruiting | Sponsor: Shanghai Pudong Hospital

CAR T-Cell Therapy • New P1 trial • Oncology • Solid Tumor • MSLN